Analysts at Guggenheim are out with a report this morning upgrading shares of Whiting Petroleum Corp. (WLL) with a ‘Buy‘ from ‘Neutral‘ rating.
Whiting Petroleum Corp. shares are currently priced at 72.75x this year’s forecasted earnings, compared to the industry’s 68.71x earnings multiple. Ticker has a forward P/E of 34.51 and t-12 price-to-sales ratio of 1.88. EPS for the same period is $0.53.
In the past 52 weeks, shares of Denver, Colorado-based oil company have traded between a low of $24.13 and a high of $92.92 and are now at $38.56. Shares are down 51.96% year-over-year ; up 3.12% year-to-date.
Analysts at Piper Jaffray upgraded their rating on the shares of VMware, Inc. (VMW). In a research note published on Monday, the firm lifted the name with a ‘Neutral‘ from ‘Underweight‘ rating.
On valuation measures, VMware Inc. shares are currently priced at 41.68x this year’s forecasted earnings, which make them expensive compared to the industry’s 10.28x earnings multiple. Ticker has a PEG and forward P/E ratio of 1.30 and 18.52, respectively. Price/sales for the same period is 6.04 while EPS is $2.04. Currently there are 21 analysts that rate VMW a ‘Buy’, 18 rate it a ‘Hold’. 2 analysts rate it a ‘Sell’. VMW has a median Wall Street price target of $95.00 with a high target of $130.00.
PBF Energy Inc. (PBF) was raised to ‘Outperform‘ from ‘Neutral‘ and it was given a $40 price target at Credit Suisse (CS) on Monday.
PBF is up $0.13 at $29.72 on heavy volume. Midway through the trading session, 2.27 million shares of PBF Energy Inc. have exchanged hands as compared to its average daily volume of 1.66 million shares. The stock has been ranging in a price between $29.33-$30.36 after having opened the day at $29.61, as compared to the previous trading day’s close of $29.59.
In the past 52 weeks, shares of the refiner of petroleum products have traded between a low of $21.02 and a high of $32.48. Shares are up 13.15% year-over-year and 12.17% year-to-date.
Aveo Pharmaceuticals, Inc. (AVEO) was upgraded to ‘Sector Perform‘ from ‘Underperform‘ by RBC Capital Markets analysts on Monday. The broker also raised its price target on the stock to $3.00 from $2.00.
AVEO is currently printing a higher than average trading volume with the issue trading 5.73 million shares, compared to the average volume of 1.24 million. The stock began trading this morning at $1.84 to currently trade 7.33% higher from the prior days close of $1.50. On an intraday basis it has gotten as low as $1.58 and as high as $1.84.
On valuation measures, Aveo Pharmaceuticals Inc. has a t-12 price-to-sales ratio of 4.29. EPS for the same period registers at ($1.01). The name has advanced 57.89% in the last 4 weeks and 74.42% in the past three months. Over the past 5 trading sessions it has gained 20.00%.
The Cambridge, Massachusetts-based biopharmaceutical company, which is currently valued at $83.40 million, has a median Wall Street price target of $1.50 with a high target of $3.00. AVEO Pharmaceuticals is down 20.21% year-over-year, compared with a 10.34% gain in the S&P 500.
Juniper Networks, Inc. (JNPR) had its rating hiked to ‘Buy‘ from ‘Neutral‘ by Goldman today. The firm currently has a $28 price target on the stock, up from their previous price target of $26.
JNPR shares recently gained $0.43 to $24.00. The stock is down 10.07% year-over-year and has gained roughly 5.60% year-to-date. In the past 52 weeks, shares of San Francisco, California-based company have traded between a low of $18.41 and a high of $26.88.
Juniper Networks Inc. closed Friday at $23.57. The name has a total market cap of $9.77 billion.